Intestinal mucosal immunity and type 1 diabetes: Non-negligible communication between gut and pancreas

被引:0
|
作者
Liu, Ruonan [1 ,2 ]
Zhang, Jing [1 ,2 ]
Chen, Si [3 ]
Xiao, Yang [1 ,2 ]
Hu, Jingyi [1 ,2 ]
Zhou, Zhiguang [1 ,2 ]
Xie, Lingxiang [1 ,2 ]
机构
[1] Cent South Univ, Natl Clin Res Ctr Metab Dis, Key Lab Diabet Immunol, Minist Educ, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp 2, Dept Metab & Endocrinol, Changsha, Peoples R China
[3] Hunan Normal Univ, Coll Life Sci, State Key Lab Dev Biol Freshwater Fish, Changsha, Peoples R China
来源
DIABETES OBESITY & METABOLISM | 2025年 / 27卷 / 03期
基金
中国国家自然科学基金;
关键词
gut-pancreas axis; intestinal mucosal immunity; microbiota; type; 1; diabetes; unconventional T cell; INVARIANT T-CELLS; CENTRAL-NERVOUS-SYSTEM; CELIAC-DISEASE; NOD MICE; MAIT CELLS; NKT CELLS; TH1; BIAS; PERMEABILITY; MICROBIOTA; AUTOIMMUNITY;
D O I
10.1111/dom.16101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by T cell-mediated pancreatic beta cell loss, resulting in lifelong absolute insulin deficiency and hyperglycaemia. Environmental factors are recognized as a key contributor to the development of T1D, with the gut serving as a primary interface for environmental stimuli. Recent studies have revealed that the alterations in the intestinal microenvironment profoundly affect host immune responses, contributing to the aetiology and pathogenesis of T1D. However, the dominant intestinal immune cells and the underlying mechanisms remain incompletely elucidated. In this review, we provide an overview of the possible mechanisms of the intestinal mucosal system that underpin the pathogenesis of T1D, shedding light on the roles of both non-classical and classical immune cells in T1D. Our goal is to gain insights into how modulating these immune components may hold potential implications for T1D prevention and provide novel perspectives for immune-mediated therapy.
引用
收藏
页码:1045 / 1064
页数:20
相关论文
共 50 条
  • [21] Comparing Outcomes and Cost Between Pancreas Transplant and Standard of Care in Patients With Type 1 Diabetes
    Jarmi, Tambi
    Thao, Viengneesee
    Borah, Bijan J.
    Brennan, Emily
    Moriarty, James P.
    Spaulding, Aaron C.
    PANCREAS, 2022, 51 (05) : 483 - 489
  • [22] The role of genetic risk factors, diet, and gut microbiota in type 1 diabetes mellitus, pancreas and pancreatic islet transplantation
    Zawada, Agnieszka
    Skrzypczak-Zielinska, Marzena
    Gondek, Sarah
    Witkowski, Piotr
    Rychter, Anna M.
    Ratajczak-Pawlowska, Alicja E.
    Karczewski, Marek
    Dobrowolska, Agnieszka
    Krela-Kazmierczak, Iwona
    ENDOKRYNOLOGIA POLSKA, 2024, 75 (02) : 140 - 147
  • [23] MAIT Cells: A Link between Gut Integrity and Type 1 Diabetes
    Gulden, Elke
    Palm, Noah
    Herold, Kevan C.
    CELL METABOLISM, 2017, 26 (06) : 813 - 815
  • [24] Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study
    Harbison, Jessica E.
    Roth-Schulze, Alexandra J.
    Giles, Lynne C.
    Tran, Cuong D.
    Ngui, Katrina M.
    Penno, Megan A.
    Thomson, Rebecca L.
    Wentworth, John M.
    Colman, Peter G.
    Craig, Maria E.
    Morahan, Grant
    Papenfuss, Anthony T.
    Barry, Simon C.
    Harrison, Leonard C.
    Couper, Jennifer J.
    PEDIATRIC DIABETES, 2019, 20 (05) : 574 - 583
  • [25] Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM
    Kobayashi, Tetsuro
    Nishida, Yoriko
    Tanaka, Shoichiro
    Aida, Kaoru
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (08) : 965 - 970
  • [26] Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes
    Maffeis, Claudio
    Martina, Alessia
    Corradi, Massimiliano
    Quarella, Sara
    Nori, Nicole
    Torriani, Sandra
    Plebani, Mario
    Contreas, Giovanna
    Felis, Giovanna E.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (07) : 700 - 709
  • [27] Emerging trends and focus on the link between gut microbiota and type 1 diabetes: A bibliometric and visualization analysis
    Guo, Keyu
    Li, Jiaqi
    Li, Xia
    Huang, Juan
    Zhou, Zhiguang
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [28] Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes
    Sathkumara, Harindra D.
    Muruganandah, Visai
    Cooper, Martha M.
    Field, Matt A.
    Alim, Md Abdul
    Brosch, Roland
    Ketheesan, Natkunam
    Govan, Brenda
    Rush, Catherine M.
    Henning, Lars
    Kupz, Andreas
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (34) : 20848 - 20859
  • [29] Crosstalk Between Immunity System Cells and Pancreas. Transformation of Stem Cells Used in the 3D Bioprinting Process as a Personalized Treatment Method for Type 1 Diabetes
    Niedzwiedzka-Rystwej, Paulina
    Wolacewicz, Mikolaj
    Cywoniuk, Piotr
    Klak, Marta
    Wszola, Michal
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2020, 68 (02)
  • [30] Association Between Circulating Vitamin K Levels, Gut Microbiome, and Type 1 Diabetes: A Mendelian Randomization Study
    de la Barrera, Samuel
    de la Barrera, Benjamin
    Legault, Marc-Andre
    Gamache, Isabel
    Manousaki, Despoina
    NUTRIENTS, 2024, 16 (22)